The Motley Fool··Reuben Gregg BrewerPfizer's 50% Decline Masks Hidden Opportunity in High-Yield Recovery Play
Pfizer's 50% stock decline masks a 6.4% dividend yield and strategic repositioning in GLP-1 drugs, oncology, and migraine treatments, offering potential upside for patient investors.
PFELLYbiotechdividend yield